gip and glp 1 receptor agonist New Weight-Loss Drugs Are Poised to Upend Preventive Cardiology Care in Patients With Obesity Overweight Dual GIP/GLP-1 receptor agonists: New

Careful consideration of patient selection criteria and possible side effects, such as gastrointestinal discomfort and hypoglycemia, will be important when using GLP-1RAs for the treatment of IIH

Extracellular vesicle-based interorgan transport of mitochondria from energetically stressed adipocytes

Dahl D, Onishi Y, Norwood P, Huh R, Bray R, Patel H, Rodriguez A

This progressive disease can lead to permanent central vision loss

Improvements in neuropathy severity scores and sensory nerve conduction were observed, and follow-up at three months indicated sustained reductions in nerve CSA and enhanced clinical outcomes